Literature DB >> 25261448

Characterization of ATP alternations in an Alzheimer's disease transgenic mouse model.

Cheng Zhang1, Robert A Rissman2, June Feng3.   

Abstract

Mitochondrial impairment as evidenced by decline in adenosine 5'-triphosphate (ATP) is associated with oxidative stress in Alzheimer's disease neuropathology and suggests that mitochondria may fail to maintain cellular energy, through reduced ATP production in neurons. To gain insights into the ATP characteristics of Alzheimer's disease transgenic (Tg) mice, we investigated ATP contents in the brain and whole blood of Tg mice at three ages (1-, 5-, and 24-months old). Overall, our results demonstrate that tissue ATP contents in Tg mice are significantly reduced, suggesting a decrease of tissue ATP production and mitochondrial dysfunction.

Entities:  

Keywords:  Adenosine 5′-triphosphate (ATP) contents; Alzheimer's disease; Alzheimer's disease transgenic mouse model; oxidative stress

Mesh:

Substances:

Year:  2015        PMID: 25261448      PMCID: PMC4305018          DOI: 10.3233/JAD-141890

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  18 in total

1.  Co-expression of multiple transgenes in mouse CNS: a comparison of strategies.

Authors:  J L Jankowsky; H H Slunt; T Ratovitski; N A Jenkins; N G Copeland; D R Borchelt
Journal:  Biomol Eng       Date:  2001-06

2.  Prediction of S-glutathionylated proteins progression in Alzheimer's transgenic mouse model using principle component analysis.

Authors:  Cheng Zhang; Ching-Chang Kuo; Alan W L Chiu; June Feng
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

3.  STARTing to understand MLN64 function in cholesterol transport.

Authors:  Attilio Rigotti; David E Cohen; Silvana Zanlungo
Journal:  J Lipid Res       Date:  2010-05-28       Impact factor: 5.922

Review 4.  Oxidative stress, inflammation, and cancer: how are they linked?

Authors:  Simone Reuter; Subash C Gupta; Madan M Chaturvedi; Bharat B Aggarwal
Journal:  Free Radic Biol Med       Date:  2010-09-16       Impact factor: 7.376

5.  S-Glutathionyl quantification in the attomole range using glutaredoxin-3-catalyzed cysteine derivatization and capillary gel electrophoresis with laser-induced fluorescence detection.

Authors:  Cheng Zhang; Cynthia Rodriguez; Magdalena L Circu; Tak Yee Aw; June Feng
Journal:  Anal Bioanal Chem       Date:  2011-08-13       Impact factor: 4.142

6.  Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension.

Authors:  Peizhong Mao; Maria Manczak; Marcus J Calkins; Quang Truong; Tejaswini P Reddy; Arubala P Reddy; Ulziibat Shirendeb; Herng-Hsiang Lo; Peter S Rabinovitch; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2012-04-05       Impact factor: 6.150

Review 7.  Aberrant subcellular neuronal calcium regulation in aging and Alzheimer's disease.

Authors:  Simonetta Camandola; Mark P Mattson
Journal:  Biochim Biophys Acta       Date:  2010-10-13

Review 8.  Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology.

Authors:  Paula I Moreira; Cristina Carvalho; Xiongwei Zhu; Mark A Smith; George Perry
Journal:  Biochim Biophys Acta       Date:  2009-10-21

9.  Contribution of mitochondrial GSH transport to matrix GSH status and colonic epithelial cell apoptosis.

Authors:  Magdalena L Circu; Cynthia Rodriguez; Ronald Maloney; Mary Pat Moyer; Tak Yee Aw
Journal:  Free Radic Biol Med       Date:  2007-09-25       Impact factor: 7.376

Review 10.  Oxidative stress and mitochondrial dysfunction in Alzheimer's disease.

Authors:  Xinglong Wang; Wenzhang Wang; Li Li; George Perry; Hyoung-gon Lee; Xiongwei Zhu
Journal:  Biochim Biophys Acta       Date:  2013-11-01
View more
  19 in total

1.  Corticotropin-Releasing Factor Receptor-1 Antagonism Reduces Oxidative Damage in an Alzheimer’s Disease Transgenic Mouse Model.

Authors:  Cheng Zhang; Ching-Chang Kuo; Setareh H Moghadam; Louise Monte; Kenner C Rice; Robert A Rissman
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

2.  Type 2 diabetes induced oxidative brain injury involves altered cerebellar neuronal integrity and elemental distribution, and exacerbated Nrf2 expression: therapeutic potential of raffia palm (Raphia hookeri) wine.

Authors:  Ochuko L Erukainure; Omamuyovwi M Ijomone; Olakunle Sanni; Michael Aschner; Md Shahidul Islam
Journal:  Metab Brain Dis       Date:  2019-06-14       Impact factor: 3.584

Review 3.  Targeting Mitochondria in Alzheimer Disease: Rationale and Perspectives.

Authors:  Chiara Lanzillotta; Fabio Di Domenico; Marzia Perluigi; D Allan Butterfield
Journal:  CNS Drugs       Date:  2019-10       Impact factor: 5.749

4.  Alterations in Cerebral Cortical Glucose and Glutamine Metabolism Precedes Amyloid Plaques in the APPswe/PSEN1dE9 Mouse Model of Alzheimer's Disease.

Authors:  Jens V Andersen; Sofie K Christensen; Blanca I Aldana; Jakob D Nissen; Heikki Tanila; Helle S Waagepetersen
Journal:  Neurochem Res       Date:  2016-09-29       Impact factor: 3.996

5.  Corticotropin-releasing factor receptor-1 modulates biomarkers of DNA oxidation in Alzheimer's disease mice.

Authors:  Cheng Zhang; Robert A Rissman
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

6.  Drp1/Fis1 interaction mediates mitochondrial dysfunction, bioenergetic failure and cognitive decline in Alzheimer's disease.

Authors:  Amit U Joshi; Nay L Saw; Mehrdad Shamloo; Daria Mochly-Rosen
Journal:  Oncotarget       Date:  2017-12-22

7.  MH84 improves mitochondrial dysfunction in a mouse model of early Alzheimer's disease.

Authors:  Maximilian Pohland; Maren Pellowska; Heike Asseburg; Stephanie Hagl; Martina Reutzel; Aljoscha Joppe; Dirk Berressem; Schamim H Eckert; Mario Wurglics; Manfred Schubert-Zsilavecz; Gunter P Eckert
Journal:  Alzheimers Res Ther       Date:  2018-02-13       Impact factor: 6.982

8.  The mitochondrial ATP synthase is a shared drug target for aging and dementia.

Authors:  Joshua Goldberg; Antonio Currais; Marguerite Prior; Wolfgang Fischer; Chandramouli Chiruta; Eric Ratliff; Daniel Daugherty; Richard Dargusch; Kim Finley; Pau B Esparza-Moltó; José M Cuezva; Pamela Maher; Michael Petrascheck; David Schubert
Journal:  Aging Cell       Date:  2018-01-07       Impact factor: 9.304

9.  Role of physical exercise in Alzheimer's disease.

Authors:  Wei-Wei Chen; Xia Zhang; Wen-Juan Huang
Journal:  Biomed Rep       Date:  2016-02-22

Review 10.  Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease.

Authors:  Simona Magi; Pasqualina Castaldo; Maria Loredana Macrì; Marta Maiolino; Alessandra Matteucci; Guendalina Bastioli; Santo Gratteri; Salvatore Amoroso; Vincenzo Lariccia
Journal:  Biomed Res Int       Date:  2016-06-02       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.